CRCL reported on August 5, bounced nearly 5% the following session to $63.25, and yet short sellers have not flinched — a divergence that frames the central tension heading into the next earnings event already scheduled for August 10.
Short interest has continued climbing through the print. It now stands at 13.0% of the free float, up from the ~12.6% flagged in the pre-earnings note published three days ago, and up roughly 20% over the past month. That is a meaningful and sustained build for a recently listed name, and it represents bears doubling down even as the stock recovered intraday. The borrow market, however, is not flashing squeeze pressure. Availability has actually tightened from the 208% range seen last week to around 154% — still firmly in the "moderate supply" zone, meaning lenders are not scrambling. Cost to borrow has also drifted lower, edging down another 4% on the week to just 0.42%. The short thesis is gaining adherents, but the mechanics remain frictionless. Options traders are incrementally more cautious than usual — the put/call ratio has crept to 0.76, a touch above its 20-day average of 0.74, and the z-score of 1.14 places it modestly elevated without screaming alarm. Positioning looks cautious rather than crowded.
The Street is split in a way that mirrors the data. TD Cowen initiated coverage at Buy with an $82 target just this week — one of the more constructive recent calls, though still well below the consensus mean of $113.72. That consensus mean deserves scrutiny: with the stock at $63.25, it implies roughly 80% upside, which likely reflects targets set before the sustained post-IPO re-rating lower. Mizuho's recent history captures the mood swings well — the firm downgraded to Underperform on July 14 with a $50 target, then upgraded back to Neutral on July 31 while simultaneously cutting the target to $45. Goldman Sachs trimmed to $96 in early July, Baird cut from $138 to $100, and Compass Point upgraded from Sell but slashed its target from $97 to $55. The direction of travel across the Street is lower targets even where ratings are improving — a signal that analysts are resetting valuation anchors after the stock's 20%-plus decline from IPO highs. The EV/EBITDA multiple has been drifting up modestly over the past month (+0.75x to 18.3x), which is notable given the weaker price action: shrinking market cap against a slowly rising multiple implies earnings estimates are being trimmed faster than the stock is falling. The ORTEX short score has also moved steadily higher, reaching 64.5 on August 4 from 60.7 just two weeks prior — a meaningful directional shift.
The bull case rests on a genuinely impressive operational story. USDC circulation grew 72% year-over-year to $75.3 billion, and Circle's share of stablecoin transaction volume rose from 39% in Q3 2025 to nearly 50% in Q4 2025. Total revenue hit $770 million on 77% year-on-year growth. Bears counter that reserve yield revenues — a core earnings driver — face structural pressure from falling interest rates, and that the Circle Payments Network has not yet delivered the adoption that justifies the original valuation. Those competing narratives were not resolved by the August 5 print; they will be tested again at the August 10 event.
Insider activity adds another layer of caution. Founder and director Patrick Neville sold roughly $2.8 million of stock across three transactions on August 3 alone, the day before the results release. The CFO and CTO both sold on July 31. Net insider activity over the past 90 days is technically positive at around $7.9 million, but that figure reflects earlier buying being offset by a recent and concentrated wave of selling from multiple executives. None of the individual transactions carry high significance scores, and many may reflect pre-arranged plans, but the clustering is hard to ignore entirely. Among closest correlated peers, MSTR gained about 1.5% on the week and SOUN added 4.3%, while CRCL slipped 1.7% — suggesting the crypto-adjacent bid that lifted peers did not fully extend to Circle.
The next print on August 10 arrives five days after the first one, an unusually compressed reporting sequence that will keep positioning active. The question is whether the stock's 5% post-earnings bounce has done anything to shake bears loose — or whether the continued short build through the print suggests they are treating the recovery as an opportunity rather than a warning.
See the live data behind this article on ORTEX.
Open CRCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
